When dialogue between industry and regulators is too cozy

• In: G2 - Regulatory dialogue in building sustainable environment for pharma innovation on Monday, 30 August 2010, 9:00-12:00
• At: Lisbon (Portugal) (2010)
• Type: Presentation
• By: LEUFKENS, Bert (Utrecht University, Utrecht, Netherlands)
• Abstract:

  Pharmaceutical regulation has many of its roots in societal concerns about the safety, quality or the lack of efficacy regarding medicinal products. Most regulatory systems around drug approval, and risk management when the drug is on the market, are designed to protect individual patients and the public at large against products with an

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login